Nabil Shabshab - Sep 1, 2023 Form 4 Insider Report for Inogen Inc (INGN)

Role
CEO and President, Director
Signature
/s/ Leslyn Cicekli, as Attorney-in-Fact
Stock symbol
INGN
Transactions as of
Sep 1, 2023
Transactions value $
-$12,002
Form type
4
Date filed
9/5/2023, 06:23 PM
Previous filing
Jun 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INGN Common Stock Options Exercise $0 +3.69K +10.46% $0.00 38.9K Sep 1, 2023 Direct
transaction INGN Common Stock Tax liability -$12K -1.94K -4.99% $6.18 37K Sep 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INGN Restricted Stock Unit Options Exercise $0 -1.57K -25.01% $0.00 4.7K Sep 1, 2023 Common Stock 1.57K Direct F2, F3
transaction INGN Restricted Stock Unit Options Exercise $0 -2.12K -33.33% $0.00 4.23K Sep 1, 2023 Common Stock 2.12K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2023.
F2 Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F3 Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years.
F4 Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years.